http://www.yso.fi/onto/yso/p2354 highly specific drugs
highly specific drugs
Avidin-biotin technology and targeted treatment of malignant glioma
Effects of add-on mirtazapine on neurocognition in schizophrenia
Imaging and properties of extrasynaptic GABA [subA] receptors in the brain
Targeted therapy sensitivity and resistance in solid malignancies
Neuronal histamine and H3 receptor in alcohol-related behaviors : focus on the interaction with the dopaminergic system
Structural determinants of Î±[sub2A]-adrenoceptor ligand binding and receptor activation
Quantitative molecular pharmacology and informatics in drug discovery
Structural determinants of [alpha][sub2A]-adrenoceptor ligand binding and receptor activation
